By contrast, in individuals with more severe forms of COVID-19 (e.g., presenting pneumonia) IL-33 may paradoxically upregulate ST2 (its own receptor on Treg cells), with an inhibitory effect on the suppressive functions of these lymphocytes [71]. This evidence concerns the gene IL33 and COVID-19.